Summary
A collection of news and information related to Schering Plough Corporation published by Tribune Company sources.
» Search within 39 items
1
2
3
4
>
39 items on Schering Plough Corporation
1
2
3
4
>
-
Pfizer, Wyeth Benefit From Overseas Growth
Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies — nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. U.K.-based GlaxoSmithKline PLC,...Tags: GlaxoSmithKline, Emerging Market, Merck & Company Incorporated, Pharmaceuticals, Sales
-
Cholesterol drug faulted in study
TRENTON, N.J. In the latest disappointment for the cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery. Results of a preliminary...Tags: Merck & Company Incorporated, Medicine, Western Medicines
-
New Jersey: Cholesterol pill fails to lower risks
In the latest disappointment for the cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery. Results of a preliminary analysis of...Tags: Merck & Company Incorporated, Death and Dying, Diseases, Heart Disease
-
Vytorin Misses Study Goal
In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found that the drug did not prevent worsening of the disease or lower the need for valve surgery, sending its makers' stock plunging....Tags: Merck & Company Incorporated, Death and Dying, Kenilworth, Diseases, Heart Disease
-
Cholesterol pill Vytorin fails heart-valve test in Europe
In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart-valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery, sending its makers' stock plunging. Results...Tags: Merck & Company Incorporated, Death and Dying, Animal Science, Waste, University of Wisconsin-Madison
-
Vytorin study sends makers' stock plunging
Tribune wire reportsTRENTON, N.J. _ A major European study in patients with heart valve disease found the drug Vytorin didn't prevent worsening of the disease or lower the need for surgery, sending its makers' stock plunging. Results of a preliminary analysis of the just-...Tags: Surgery, Sales, Parliament, Diseases, Cancer
-
Oil, profit-taking nudge stocks down
Wall Street lost ground, with investors pulling back from last week's big rally as they watched the price of oil advance. The tame session unfolded as oil rose on concerns that the threat of new sanctions against Iran over its nuclear program could...Tags: Banking, Merck & Company Incorporated, Bank of America Corp., Economic Sanctions, Foreign Aid
-
How to use sunscreen wisely
Chicago TribuneSunscreen is commonly hailed as safe, essential body armor. It protects us from blistering sunburn, keeps our skin from wrinkling and helps guard against squamous cell cancer. But the evidence is inconclusive as to whether sunscreens reduce the risk of...Tags: Johnson & Johnson Incorporated, Medical Specialization, Health Organizations, Diseases, Cancer
-
NJ to lose more than 800 pharmaceutical jobs
More than 800 pharmaceutical jobs will be leaving New Jersey starting in August. Most of the job cuts and transfers are part of major previously announced restructurings at Johnson & Johnson and Schering-Plough Corp. This week, the companies specified...Tags: Kenilworth, Centocor Incorporated, Abbott Laboratories
-
Overdiversification Hinders Huge Mutual Funds
Most managed stock mutual funds have underperformed the market, as measured by the Standard & Poor's 500, an index that tracks 500 of America's leading companies. The problem is partly size. Imagine running a $40 billion mutual fund. That might sound...Tags: Cheesecake Factory Incorporated (The), Google Inc., Merck & Company Incorporated, Pharmaceuticals, Mutual Funds
Jul 24, 2008
|Story| Hartford Courant
Jul 22, 2008
|Story| Baltimore Sun
Jul 22, 2008
|Story| South Florida Sun-Sentinel
Jul 22, 2008
|Story| Hartford Courant
Jul 22, 2008
|Story| Orlando Sentinel
Jul 21, 2008
|Story| Chicago Tribune
Jul 22, 2008
|Story| Chicago Tribune
Jul 15, 2008
|Story| South Florida Sun-Sentinel
Jul 8, 2008
|Story| Associated Press
Jul 13, 2008
|Story| Hartford Courant
